In Multiple Sclerosis (MS), which is also a demyelinating neuroinflammatory disease, it is thought that CXCL9 and CXCL10 in the CSF are involved in the recruitment of CXCR3+ T cells into CNS and contribute to MS pathogenesis (Müller et al., 2010; Cheng and Chen, 2014; Vazirinejad et al., 2014; Koper et al., 2018). This evidence concerns the gene CXCL10 and myeloid sarcoma.